Axillary reverse mapping using near-infrared fluorescence imaging in invasive breast cancer (ARMONIC study)

Eur J Surg Oncol. 2022 Dec;48(12):2393-2400. doi: 10.1016/j.ejso.2022.07.004. Epub 2022 Jul 8.

Abstract

Background: Axillary lymph node dissection (ALND) in patients with breast cancer has potential side effects, including upper-limb lymphedema. Axillary reverse mapping (ARM) is a technique that enables discrimination of the lymphatic drainage of the upper limb in the axillary lymph node basin from that of the breast. We aimed to evaluate ARM node identification by near-infrared (NIR) fluorescence imaging during total mastectomy with ALND and then to analyze potential predictive factors of ARM node involvement.

Methods: The study enrolled 119 patients diagnosed with invasive breast cancer with an indication for ALND. NIR imaging using indocyanine green dye was performed in 109 patients during standard ALND to identify ARM nodes and their corresponding lymphatic ducts.

Results: 94.5% of patients had ARM nodes identified (95%CI = [88.4-98.0]). The ARM nodes were localized in zone D in 63.4% of cases. Metastatic axillary lymph nodes were found in 55% in the whole cohort, and 19.4% also had metastasis in ARM nodes. Two patients had metastatic ARM nodes but not in the remaining axillary lymph nodes. No serious adverse events were observed. Only the amount of mitosis was significantly associated with ARM node metastasis.

Conclusions: ARM by NIR fluorescence imaging could be a reliable technique to identify ARM nodes in real-time when ALND is performed. The clinical data compared with ARM node histological diagnosis showed only the amount of mitosis in the diagnostic biopsy is a potential predictive factor of ARM node involvement.

Clinical trial registration: NCT02994225.

Keywords: Axillary reverse mapping; Breast cancer; Fluorescence; Indocyanine green lymphadenectomy; Sentinel lymph node.

Publication types

  • Clinical Trial

MeSH terms

  • Axilla / pathology
  • Breast Neoplasms* / diagnostic imaging
  • Breast Neoplasms* / etiology
  • Breast Neoplasms* / surgery
  • Female
  • Humans
  • Lymph Node Excision / methods
  • Lymph Nodes / diagnostic imaging
  • Lymph Nodes / pathology
  • Lymph Nodes / surgery
  • Lymphedema* / etiology
  • Mastectomy / methods
  • Optical Imaging
  • Sentinel Lymph Node Biopsy / methods

Associated data

  • ClinicalTrials.gov/NCT02994225